GBS Inc. to Hold Virtual 2022 Annual Shareholder Meeting on Thursday, June 16, 2022, at 4:00pm ET
May 13, 2022 09:05 ET
|
GBS, Inc.
NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners...
GBS Inc. to Present Third Quarter 2022 Financial Results and Recent Corporate Update on May 10
May 03, 2022 09:05 ET
|
GBS, Inc.
NEW YORK, May 03, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners...
GBS Inc. Announces Institutional Review Board Approval to Initiate Clinical Trial at Sutter Health Mills-Peninsula Medical Center
March 31, 2022 16:05 ET
|
GBS, Inc.
The trial is single center, prospective study to collect coincident samples of oral fluid and blood to evaluate the time-course of glucose Trial is expected to enroll approximately 40 adult subjects...
GBS Inc. to Participate in the Upcoming March Investor Conferences
March 07, 2022 08:30 ET
|
GBS, Inc.
NEW YORK, March 07, 2022 (GLOBE NEWSWIRE) -- GBS (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at...
GBS Inc. to Present Second Quarter 2022 Financial Results and Recent Corporate Update on February 10
February 07, 2022 08:30 ET
|
GBS, Inc.
NEW YORK, Feb. 07, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners...
GBS Inc. to Participate in the Upcoming January Virtual Investor Conferences
December 20, 2021 07:10 ET
|
GBS, Inc.
NEW YORK, Dec. 20, 2021 (GLOBE NEWSWIRE) -- GBS (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at...
GBS Inc. Announces Application for FDA Breakthrough Device Designation to Fast Track Rapid Saliva Glucose Test
December 13, 2021 08:00 ET
|
GBS, Inc.
NEW YORK, Dec. 13, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners...
GBS Inc. Announces Plans for Clinical SARS-CoV-2 Antibody Trials Following Validation Study
November 30, 2021 08:00 ET
|
GBS, Inc.
NEW YORK, Nov. 30, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners...